Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Cocrystal Discovery Secures Financing

September 29, 2008 | A version of this story appeared in Volume 86, Issue 39

Cocrystal Discovery, a biopharmaceutical firm founded by two former Icos employees and Roger Kornberg, recipient of the 2006 Nobel Prize in Chemistry, has secured $10 million in its first round of financing. The Frost Group led the investors, and founder Phil Frost will join Cocrystal's board. Cocrystal, formed after Icos was acquired by Eli Lilly & Co. last year, will focus on using structure-based drug discovery to find antiviral compounds that target replication enzymes.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.